{
    "Trade/Device Name(s)": [
        "Xpert vanA",
        "Xpert vanA Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K092953",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061686",
        "K972359"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NIJ",
        "OO1"
    ],
    "Summary Letter Date": "December 17, 2008",
    "Summary Letter Received Date": "September 24, 2009",
    "Submission Date": "September 23, 2009",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "vanA gene"
    ],
    "Specimen Type(s)": [
        "Rectal swab"
    ],
    "Specimen Container(s)": [
        "Double swab with tube containing elution reagent"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Qualitative nucleic acid amplification",
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "Genotypic detection",
        "Automated sample preparation",
        "Real-time PCR amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert vanA Assay, a rapid automated PCR-based test to detect the vanA gene associated with vancomycin resistance in rectal swab specimens.",
    "Indications for Use Summary": "Intended for rapid qualitative detection of the vanA gene sequence associated with vancomycin resistance in bacteria from rectal swabs of patients at risk for intestinal colonization with vancomycin-resistant bacteria, to aid in recognition, prevention, and control of vancomycin-resistant organisms in healthcare settings; not for diagnosis or treatment guidance.",
    "fda_folder": "Microbiology"
}